Ipilimumab/nivolumabVarious toxicities and lack of efficacy: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1924卷 / 1期

关键词：

D O I：

10.1007/s40278-022-23613-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：260 / 260

相关论文

共 50 条

[31] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2017, 1676 (1) : 175 - 175
[32] Ipilimumab/nivolumabVarious toxicities: 3 case reports
Reactions Weekly, 2022, 1902 (1) : 255 - 255
[33] Ipilimumab/nivolumabVarious toxicities: 3 case reports
Reactions Weekly, 2021, 1865 (1) : 242 - 242
[34] Ipilimumab/nivolumabVarious toxicities: 5 case reports
Reactions Weekly, 2019, 1737 (1) : 172 - 172
[35] Ipilimumab/nivolumabVarious toxicities: 18 case reports
Reactions Weekly, 2018, 1705 (1) : 175 - 175
[36] Ipilimumab/nivolumabVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1693 (1) : 278 - 278
[37] Avelumab/ipilimumab/nivolumabVarious toxicities: 7 case reports
Reactions Weekly, 2021, 1837 (1) : 88 - 88
[38] Ipilimumab/nivolumabVarious toxicities and no response: 2 case reports
Reactions Weekly, 2022, 1920 (1) : 269 - 269
[39] Denosumab/ipilimumab/nivolumabVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1763 (1) : 133 - 133
[40] Avelumab/ipilimumab/nivolumabVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1981 (1) : 75 - 75

← 1 2 3 4 5 →